Literature DB >> 26697181

Successful treatment of aortic root abscess in a patient with pulmonary arterial hypertension.

Amitesh Agarwal1, Andras Kollar2, Alexander G Duarte1.   

Abstract

Continuous prostanoid infusion is an established treatment for pulmonary arterial hypertension that has led to improvements in symptoms, exercise tolerance, and survival. Patients with pulmonary arterial hypertension (PAH) who develop sepsis frequently experience clinical and hemodynamic deterioration associated with poor outcomes. Successful management of sepsis involves identification of the source of infection, early antimicrobial administration, judicious fluid resuscitation, and continuation of specific PAH therapies. We describe successful management of a patient with idiopathic PAH receiving chronic intravenous prostacyclin therapy who developed an aortic root abscess due to Clostridium perfringens requiring emergent aortic root repair. Management involved imaging studies, removal of potential sources with administration of intravenous antibiotics, and cautious fluid administration with hemodynamic monitoring. A multidisciplinary group led by a PAH specialist worked cohesively before, during, and after surgical intervention and achieved a successful outcome.

Entities:  

Keywords:  Clostridium perfringens; infective endocarditis; perioperative management; pulmonary hypertension

Year:  2015        PMID: 26697181      PMCID: PMC4671748          DOI: 10.1086/683688

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  16 in total

Review 1.  Perioperative risk and management in patients with pulmonary hypertension.

Authors:  Omar A Minai; Jean-Pierre Yared; Roop Kaw; Kathirvel Subramaniam; Nicholas S Hill
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

2.  Prevention of right heart failure after left ventricular assist device implantation by phosphodiesterase 5 inhibitor.

Authors:  Righab Hamdan; Hassan Mansour; Pierre Nassar; Mohamad Saab
Journal:  Artif Organs       Date:  2014-04-02       Impact factor: 3.094

3.  Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey.

Authors:  Stephanie Meyer; Vallerie V McLaughlin; Hans-Juergen Seyfarth; Todd M Bull; Carmine D Vizza; Mardi Gomberg-Maitland; Ioana R Preston; Joan A Barberà; Paul M Hassoun; Michael Halank; Xavier Jaïs; Nils Nickel; Marius M Hoeper; Marc Humbert
Journal:  Eur Respir J       Date:  2012-11-08       Impact factor: 16.671

Review 4.  Intensive care unit management of patients with severe pulmonary hypertension and right heart failure.

Authors:  Marius M Hoeper; John Granton
Journal:  Am J Respir Crit Care Med       Date:  2011-11-15       Impact factor: 21.405

5.  Preliminary experience with inhaled milrinone in cardiac surgery.

Authors:  Yoan Lamarche; Louis P Perrault; Simon Maltais; Karine Tétreault; Jean Lambert; André Y Denault
Journal:  Eur J Cardiothorac Surg       Date:  2007-04-02       Impact factor: 4.191

Review 6.  Endocarditis due to rare and fastidious bacteria.

Authors:  P Brouqui; D Raoult
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

7.  Endocarditis complicating central venous catheter bloodstream infections: a unique form of health care associated endocarditis.

Authors:  Michael P Chrissoheris; Claudia Libertin; Ronan G Ali; Andre Ghantous; Amenuve Bekui; Thomas Donohue
Journal:  Clin Cardiol       Date:  2009-12       Impact factor: 2.882

8.  Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.

Authors:  Hongmei Wang; Ming Gong; Bin Zhou; Anlu Dai
Journal:  Adv Ther       Date:  2009-04-16       Impact factor: 3.845

9.  Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.

Authors:  B Sztrymf; R Souza; L Bertoletti; X Jaïs; O Sitbon; L C Price; G Simonneau; M Humbert
Journal:  Eur Respir J       Date:  2009-11-06       Impact factor: 16.671

10.  Bloodstream infections in patients given treatment with intravenous prostanoids.

Authors:  Alexander J Kallen; Edith Lederman; Alexandra Balaji; Ingrid Trevino; Emily E Petersen; Rivka Shoulson; Lisa Saiman; Evelyn M Horn; Mardi Gomberg-Maitland; Robyn J Barst; Arjun Srinivasan
Journal:  Infect Control Hosp Epidemiol       Date:  2008-04       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.